EE184 Assessing the Cost-Effectiveness of the Novavax COVID-19 Vaccine as a Potential Booster Vaccine Option for Adults in the United States
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.434
https://www.valueinhealthjournal.com/article/S1098-3015(22)02638-9/fulltext
Title :
EE184 Assessing the Cost-Effectiveness of the Novavax COVID-19 Vaccine as a Potential Booster Vaccine Option for Adults in the United States
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02638-9&doi=10.1016/j.jval.2022.09.434
First page :
Section Title :
Open access? :
No
Section Order :
12242